Was the Apple Heart Study Virtually Useless?

Was the Apple Heart Study Virtually Useless? Posted By:
...

My wife absolutely loves her Apple Watch and would admit that it is like her crack cocaine: she feels compelled to close all of her rings daily, even when we are on vacation. Clearly, it can be a great motivator for many. But can it also be a tool for preventive medicine?

When Apple included in the watch the capability of providing public health apps in detecting things such as falls and irregular pulses, many began to ponder its actual utility. Stanford University researchers asked if the watch could detect and notify the user of atrial fibrillation (AFib) based upon an algorithm, and the Apple Heart Study was implemented and enrolled nearly 420,000 people in less than one year, a remarkable accomplishment. In short, the answer is, yes, the algorithm and watch can detect irregular pulses. But is this just a gadget or is this a real medical tool with significant utility? Like it or not, consumer-driven health "gadgets" are not only here, but are likely here to stay.

Many are arguing that this trial will provide only a glimpse into what the most recent wearable devices can do. The trial had numerous flaws that would be unacceptable in traditional rigorous clinical trials. The selection bias was huge: who was enrolled? This might be better answered by asking who wants—and can afford—an Apple Watch? Apple is, by some accounts, a plaything for the young and affluent. Participants tended to be young (more than 80% under 55 years) and white (more than 70%), and this likely implies healthy people with regular access to healthcare. As expected, these individuals had low CHADS scores (87%), hence a low risk for AFib. Also, Apple Watches are typically recharged overnight, meaning that they are worn only about two-thirds of the time, a huge gap in monitoring. Additionally, 15% who signed up for the study had one or more pre-existing episodes of AFib, enriching the likelihood of picking up AFib.

Even with those biases in favor of finding AFib, the results were fairly dismal. There were 2161 individuals (0.5%) who had an irregular pulse detected by the watch, yet only 945 (44%) actually engaged with a provider to follow-up. Even in those who did, and had a wearable ECG patch sent to them, only 450 wore and returned the patch for further analysis. Nearly 80% of those who were notified of an irregular pulse were lost to follow-up, unacceptable in a traditional research study. In the end, 72 individuals (0.84%) had documented AFib, dramatically lower than what is generally accepted as a baseline rate of AFib. One important finding of the Apple Heart Study was that 20% of the AFib discovered was greater than 24 hours in duration.

So while many may claim this to be a new age for medicine, and while there are lessons to be learned for future applications, there is little ground-breaking new information here.

Reference
  • ACC News Story. Apple Heart Study identifies AFib in small group of Apple Watch wearers. www.acc.org/latest-in-cardiology/articles/2019/03/08/15/32/sat-9am-apple-heart-study-acc-2019. Accessed April 5, 2019.

Share

Filed under: Preventive Medicine , Cardiometabolic

Related
Phase III FLOW Trial Results Establishes Semaglutide’s Role in Treating T2D and CKD

Phase III FLOW Trial Results Establishes Semagluti ...

The highly anticipated results of the FLOW (Evaluate Renal Function with Semaglutide Once Weekly) tr ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
The Gift of Time and Key Connection Between Diabetes Mellitus and Autoimmune Disorders

The Gift of Time and Key Connection Between Diabet ...

Are you aware that approximately 64,000 Americans are diagnosed with type 1 diabetes (T1D) each year ...

Filed under: Cardiometabolic


Continue Reading
The Importance of Shared Decision-making in Obesity

The Importance of Shared Decision-making in Obesit ...

Many areas of healthcare are starting to talk about the importance of shared decision-making (SDM), ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
Addressing ASCVD Risk in HIV: An Update to the DHHS HIV Guidelines

Addressing ASCVD Risk in HIV: An Update to the DHH ...

The incidence of atherosclerotic cardiovascular disease (ASCVD) is estimated to be twice as high in ...

Filed under: Infectious Diseases, Preventive Medicine, Public Health, Cardiometabolic, NPs & PAs


Continue Reading
Understanding the Multifactorial Etiology of Obesity and the Metabolic Adaptations to Weight Loss

Understanding the Multifactorial Etiology of Obesi ...

Obesity Causes Overeating, Not the Other Way AroundOne of my favorite quotes from Dr Lee Kaplan is, ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
Atrial Fibrillation: Optimizing Outcomes by Addressing Social Determinants of Health and Implicit Bias

Atrial Fibrillation: Optimizing Outcomes by Addres ...

Atrial fibrillation (AF) is the most common sustained arrhythmia diagnosed, and its prevalence is ex ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading